Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Coreage Rx tops our board for one unglamorous reason: we could not find a gap between what it advertises and what it charges.
Compounded tirzepatide from $149 a month on the annual plan, $199 month-to-month. No membership renews behind it. No surcharge when your dose climbs. In a market where the advertised number is usually the opening bid, that is the story.
The numbers
| Coreage Rx · tirzepatide | |
|---|---|
| Advertised | $149/mo |
| Membership | None |
| Billed | $199/mo |
| Advertised-to-billed gap | +$50/mo |
| Per year | $2,388 |
| Board position | 1 of 18, cheapest first |
The $149 figure is the annual-plan rate. Month-to-month runs $199. Because there is no membership fee, the advertised number and the billed number are the same thing.
Where the gap is
The only asterisk worth printing is the annual plan. The $149 figure requires a twelve-month commitment; month-to-month is $199. Both are disclosed up front, and both still land below every full-dose rival on the board. Check the refund terms before prepaying a year — that is the real risk here, not a hidden fee.
Against the board
Against the board: Zealthy is next at $216, Mochi at $278 once its membership is counted, Eden at $298, MEDVi and Willow at $399, TrimRx at its billed $399, and Henry Meds at $449. Same category of compounded medication throughout.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Flat-rate telehealth program for compounded GLP-1s. The medication, the clinician visits and the ongoing check-ins are quoted as one number, with no separate membership billed alongside it.
Verified facts
- Compounded tirzepatide advertised from $149/month on the annual plan, $199/month otherwise.
- Compounded semaglutide advertised from $99/month on the annual plan.
- A three-month tirzepatide block has been offered at $589 covering any dose up to 15 mg per week.
- Pricing is flat-rate: there is no separate monthly membership stacked on top of the medication price.
- Dose increases within the covered range do not change the price, which is unusual in this market.
- Health coaching is bundled rather than sold as an upgrade.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- The advertised price is the billed price — no membership fee arrives in month two.
- Flat pricing across the dose range, so titrating up to 10 mg or 15 mg does not raise the bill.
- Lowest true monthly cost of any provider in this comparison once fees are included.
- Coaching and clinician access are included rather than sold separately.
Against it
- The headline rates require the annual commitment; month-to-month costs more.
- Compounded medication only, so there is no path to branded Zepbound or Wegovy inside the program.
- Insurance is not billed — this is a cash-pay program.
Read this bit. The $99 and $149 rates are annual-plan prices. If you want month-to-month, budget $149 and $199 instead, and check the refund terms before prepaying a year.
Score
4.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 4.9 / 5 |
| Price honesty | 20% | 4.7 / 5 |
| Clinical support | 20% | 4.3 / 5 |
| Pharmacy sourcing | 15% | 4 / 5 |
| Cancelling | 15% | 4.4 / 5 |
Verdict
Cheapest true monthly cost we track, and the cleanest pricing structure. The caveats belong to the whole compounded category rather than to this programme specifically.
More from the desk
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Fifty 410 tirzepatide review
Advertised at $133 and billed at $133 — no gap. Position 4 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.